uniQure
QURE
$4.95
Share price
5.77%
Change (1 day)
-75.97%
Change (1 year)
uniQure (QURE) - Cash on Hand
Cash on Hand as of March 2024 : $0.55 B
According to uniQure's latest financial reports the company has $0.55 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
uniQure - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.61 B | 75.12% |
| 2022-12-31 | $0.35 B | -36.57% |
| 2021-12-31 | $0.55 B | 127.11% |
| 2020-12-31 | $0.24 B | -35.17% |
| 2019-12-31 | $0.37 B | 60.83% |
| 2018-12-31 | $0.23 B | 47.39% |
| 2017-12-31 | $0.15 B | 20.28% |
| 2016-12-31 | $0.13 B | -40.22% |
| 2015-12-31 | $0.22 B | 242.46% |
| 2014-12-31 | $64.71 M | 96.83% |
| 2013-12-31 | $32.87 M | 9352.78% |
| 2012-12-31 | $0.34 M | -75.6% |
| 2011-12-31 | $1.42 M | -94% |
| 2010-12-31 | $23.75 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $9.70 B | 1,647.04% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 1,686.66% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $54.41 M | -90.21% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.17 B | -68.63% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.04 B | 88.34% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.91 B | 64.82% | 🇺🇸 USA |